Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06558214
Title OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial (OPTIMUS PRIME)
Acronym OPTIMUS PRIME
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UF Health Shands Hospital RECRUITING Gainesville Florida 32608 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field